PDHB
protein-codingpyruvate dehydrogenase E1 subunit beta, the group of Pyruvate dehydrogenase complex
Gene summary
The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and carbon dioxide, and provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDH complex is composed of multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodes the E1 beta subunit. Mutations in this gene are associated with pyruvate dehydrogenase E1-beta deficiency. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~6.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013580
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013580
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0013580
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0013580
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013580
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009723
Submitter: ClinGen
The relationship between PDHB and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of July 13, 2020. The PDHB gene encodes the E1 beta subunit of the pyruvate dehydrogenase complex (PDC). PDC catalyzes conversion of pyruvate into acetyl-CoA, thus is the link between glycolysis and the citric acid cycle. PDC deficiency leads to impaired energy metabolism. The PDHB gene was first reported in relation to autosomal recessive Leigh syndrome spectrum in 2009 (PMID: 19924563). Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included three variants identified in seven cases in two publications (PMIDs: 21914562, 19924563). Of note, those with PDHB deficiency can also have structural brain abnormalities (corpus callosum abnormalities) and microcephaly. In addition, several affected individuals have neonatal lactic acidosis, raising the possibility that some affected individuals die before they would have developed Leigh syndrome spectrum. No segregation data were available. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by known biochemical function, expression, functional alteration in patient cells, and animal models (PMIDs: 27977873, 25613900, 25356417, 29501567, 31127358). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on July 13, 2020 (SOP Version 7).
Inheritance Pattern: AR
Disease ID:MONDO:0013580
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PDHB variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000925.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 136 | 143 | |||
| missense | 4 | 8 | 80 | 4 | 96 | |
| nonsense | 3 | 7 | 2 | 12 | ||
| start loss | 1 | 1 | 1 | 3 | ||
| frameshift | 7 | 9 | 16 | |||
| splice donor/acceptor (+/-2bp) | 2 | 6 | 5 | 13 | ||
| Total | 17 | 31 | 95 | 140 | 0 | 283 |
Highest pathogenic variant AF is 0.00023761785
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000916.2 | 10 | MANE Select | |
| Ensembl | ENSP00000307241.6 | 10 | MANE Select | |
| RefSeq | NP_001166939.1 | 11 | Standard | |
| RefSeq | NP_001302465.1 | 9 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| pdhb | Danio rerio | Structure: amacrine cell Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Citrate cycle (TCA cycle) - Homo sapiens (human)
- Pyruvate metabolism - Homo sapiens (human)
- Glycolysis / Gluconeogenesis - Homo sapiens (human)
- Central carbon metabolism in cancer - Homo sapiens (human)
- HIF-1 signaling pathway - Homo sapiens (human)
Biological Process
- glucose metabolic process
- acetyl-CoA biosynthetic process from pyruvate
- tricarboxylic acid cycle
- mitochondrial acetyl-CoA biosynthetic process from pyruvate
Molecular Function
- pyruvate dehydrogenase activity
- pyruvate dehydrogenase (acetyl-transferring) activity
- protein binding
- pyruvate dehydrogenase (NAD+) activity
Cellular Component
- nucleus
- nucleoplasm
- mitochondrion
- mitochondrial matrix
- pyruvate dehydrogenase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000302746
- Coding exons
- 10
- Length
- 6228
- Individuals with no LoFs
- 125734
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 14
- Defined
- 125748
- p
- 0.0000557
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.57 | 139 | 202 | 0.690 | 0.00000975 | 2339 |
| Missense (PolyPhen) | 37 | 86.725 | 0.42664 | 1048 | ||
| Synonymous | -0.853 | 74 | 65.2 | 1.13 | 0.00000305 | 703 |
| Loss of Function | 2.98 | 5 | 19.0 | 0.263 | 8.77e-7 | 232 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.000062 | 0.000062 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle. {ECO:0000269|PubMed:17474719, ECO:0000269|PubMed:19081061}.;
- Disease
- DISEASE: Pyruvate dehydrogenase E1-beta deficiency (PDHBD) [MIM:614111]: An enzymatic defect causing primary lactic acidosis in children. It is associated with a broad clinical spectrum ranging from fatal lactic acidosis in the newborn to chronic neurologic dysfunction with structural abnormalities in the central nervous system without systemic acidosis. {ECO:0000269|PubMed:15138885}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.447
Intolerance Scores
- LoFtool
- 0.124
- RVIS EVS
- -0.41
- RVIS percentile EVS
- 26.23
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.990
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |